Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-23-000723)

Filing Details

Accession Number:: 0001140361-23-000723
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-05 21:05:36
Reporting Period:: 2022-11-21

Accepted Time:: 2023-01-05 21:05:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439725	Biodesix Inc	BDSX	Services-Medical Laboratories (8071)	203986492

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1830773	Jr T. Lawrence Kennedy	1700 Madison Road, Suite 200 Cincinnati OH 45206		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-11-21	8,260,869	$1.15	9,148,889	No	4	P	Indirect	By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01
Common Stock	Acquisiton	2022-11-21	2,608,696	$1.15	4,355,914	No	4	P	Indirect	By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By: Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01
No	4	P	Indirect	By: Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	166,666	Indirect	By: KFDI-B LLC
Common Stock	1,155,935	Indirect	By: Lair BDSX GRAT 2022-3.2

Footnotes

Reported amounts have been adjusted to reflect the September 27, 2022 transfer of 469,026 shares previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.